Derek Hainy

Derek Hainy

Healthcare Regulation Expert
Derek Hainy is a public policy expert specializing in healthcare regulation. He provides insightful analysis of the latest regulatory changes affecting healthcare providers. Focusing on compliance, Derek helps medical professionals navigate healthcare laws, requirements, and reforms. He also covers the future of healthcare data privacy regulations and the regulatory landscape for telehealth services. 
How Will Colorado's New Healthcare Rules Impact Providers?
Public Policy How Will Colorado's New Healthcare Rules Impact Providers?

In the heart of Colorado's bustling healthcare sector, a seismic shift is underway as new regulations reshape the operational landscape for providers across the state, affecting over 2,000 licensed entities. With hospitals, nursing facilities, and home care agencies grappling with evolving

FDA's New Accelerated Pathway: Risks and Rewards for Pharma
Public Policy FDA's New Accelerated Pathway: Risks and Rewards for Pharma

Imagine a world where life-saving drugs reach patients in mere months rather than years, addressing urgent medical crises with unprecedented speed, and transforming the landscape of healthcare delivery. This vision is becoming a reality through the U.S. Food and Drug Administration's latest

Breaking Data Silos in Behavioral Health for Better Care
Public Policy Breaking Data Silos in Behavioral Health for Better Care

In the intricate landscape of behavioral health, delivering high-quality care depends heavily on the ability to share and access patient information seamlessly across diverse providers and settings, yet a persistent and daunting obstacle stands in the way: data silos. These isolated repositories of

Why Is Trump Blocking Gender-Affirming Care in Federal Plans?
Public Policy Why Is Trump Blocking Gender-Affirming Care in Federal Plans?

Understanding Gender-Affirming Care and Federal Health Plans The landscape of health care for federal employees stands at a critical juncture as policies surrounding gender-affirming care come under intense scrutiny. Gender-affirming care encompasses a range of medical interventions, including

FDA Panel Debates SSRI Safety Risks During Pregnancy
Public Policy FDA Panel Debates SSRI Safety Risks During Pregnancy

Overview of SSRI Use and Maternal Mental Health Imagine a pregnant woman grappling with severe depression, torn between the need to manage her mental health and the fear of harming her unborn child with medication. This dilemma affects roughly 5% to 6% of pregnant women in North America who rely on

Health IT Infrastructure – Review
Public Policy Health IT Infrastructure – Review

Setting the Stage for Digital Healthcare Transformation Imagine a hospital where patient data flows seamlessly between departments, clinicians make decisions based on real-time insights, and operational inefficiencies are a thing of the past. This vision, while aspirational, is increasingly within

What’s Next for Healthcare at Michigan HIMSS Conference?
Public Policy What’s Next for Healthcare at Michigan HIMSS Conference?

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with deep expertise in medical technology. With years of experience in the manufacturing of medical devices for diagnostics and treatment, Faisal has been at the forefront of driving innovation in the industry. Today,

First FDA-Approved ENCELTO Treatment Performed for MacTel
Public Policy First FDA-Approved ENCELTO Treatment Performed for MacTel

Introduction Imagine living with a condition that slowly erases the clarity of central vision, making everyday tasks like reading or recognizing faces increasingly difficult, a reality for individuals diagnosed with idiopathic Macular Telangiectasia Type 2, commonly known as MacTel. This rare

DOJ Mandates 164 Divestitures for UnitedHealth-Amedisys Deal
Public Policy DOJ Mandates 164 Divestitures for UnitedHealth-Amedisys Deal

Welcome to an insightful conversation on the evolving landscape of healthcare mergers and antitrust regulations. Today, we’re joined by Faisal Zain, a renowned healthcare expert specializing in medical technology. With his deep experience in the manufacturing of diagnostic and treatment devices, F

Are New UK Cosmetic Regulations Enough to Protect Patients?
Public Policy Are New UK Cosmetic Regulations Enough to Protect Patients?

Overview of the UK Cosmetics Industry and Regulatory Context The UK cosmetics industry, particularly the aesthetics sector, stands at a critical juncture as non-surgical procedures like Botox and dermal fillers surge in popularity, transforming beauty standards across the nation and raising urgent

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later